Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis

Applied and Environmental Microbiology

Volumn 63, Issue 1, 1997, Pages 44-49

  Vollenbroich, Dirk ^a   Pauli, Georg ^b   Özel, Muhsin ^b   Vater, Joachim ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LIPOPEPTIDE; SURFACTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; BACILLUS SUBTILIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LIPID BILAYER; MONKEY; MYCOPLASMA; NONHUMAN; PNEUMONIA; UROGENITAL TRACT DISEASE;

EID: 0031015251     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.63.1.44-49.1997     Document Type: Article

References (31)

1. Arima, K., A. Kakinuma, and G. Tamura. October 1968. German patent OS 1,803,987.
2. Baumgart, F., B. Kluge, C. Ullrich, J. Vater, and D. Ziessow. 1991. Identification of amino acid substitutions in the lipopeptide surfactin using 2D NMR spectroscopy. Biochem. Biophys. Res. Commun. 177:998-1005.
3. Bernheimer, A. W., and L. S. Avigad. 1970. Nature and properties of a cytolytic agent produced by Bacillus subtilis. J. Gen. Microbiol. 61:361-369.
4. Blanchard, A., and L. Montagnier. 1994. AIDS-associated mycoplasmas. Annu. Rev. Microbiol. 48:687-712.
5. Chowdhury, M. I. H., T. Munakata, Y. Koyanagi, S. Arai, and N. Yamamoto. 1994. Mycoplasma stimulates HIV-1 expression from acutely-and dormantly-infected promonocyte/monoblastoid cell lines. Arch. Virol. 139:431-438.
6. Fleckenstein, E., C. C. Uphoff, and H. G. Drexler. 1994. Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril). Leukemia 8:1424-1434.
7. Flick, U. A., and G. E. Gifford. 1984. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68:167-175.
8. Gelderblom, H. R., E. H. S. Hausmann, M. Özel, G. Pauli, and M. A. Koch. 1987. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171-176.
9. Hay, R. J., M. L. Macy, and T. R. Chen. 1989. Mycoplasma infections of cultured cells. Nature 339:487-488.
10. Hosono, K., and H. Suzuki. 1983. Acylpeptides, the inhibitors of cyclic adenosine 3′,5′-monophosphate phosphodiesterase. III. Inhibition of cyclic AMH phosphodiesterase. J. Antibiot. (Tokyo) 36:679-683.
11. Hosono, K., and H. Suzuki. 1985. Morphological transformation of Chinese hamster cells by acylpeptides, inhibitors of cAMP phosphodiesterases, produced by Bacillus subtilis. J. Biol. Chem. 260:11252-11255.
12. Ishigami, Y., M. Osman, H. Nakahara, Y. Sano, R. Ishiguro, and M. Matsumoto. 1995. Significance of β-sheet formation for micellization and surface adsorption of surfactin. Colloids Surf. B Biointerfaces 4:341-348.
13. Kameda, Y., S. Ouhira, K. Matsui, and S. Kanatomu. 1974 Antitumor activity of Bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311. Chem. Pharm. Bull. (Tokyo) 22:938-944.
14. Lin, S.-C., M. A. Minton, M. M. Sharma, and G. Georgiou. 1994. Structural and immunological characterization of a biosurfactant produced by Bacillus licheniformis JF-2. Appl. Environ. Microbiol. 60:31-38.
15. Magel-Dana, R., and M. Ptak. 1995. Interactions of surfactin with membrane models. Biophys. J. 68:1937-1943.
16. McGarrity, G. J., V. Vanaman, and J. Sarama. 1978. Methods of prevention, control, and elimination of mycoplasma infection, p. 213-241. In G. J. McGarrity, D. G. Murphy, and W. W. Nichols (ed.), Mycoplasma infection of cell cultures. Plenum Press, New York, N.Y.
17. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65:55-63.
18. Nissen, E., D. Vollenbroich, and G. Pauli. Comparison of PCR preparation methods for mycoplasma detection in cell cultures. In Vitro Cell. Dev. Biol., in press.
19. Razin, S. 1978. The mycoplasmas. Microbiol. Rev. 42:414-470.
20. Rottem, S. 1980. Membrane lipids of mycoplasmas. Biochim. Biophys. Acta 604:65-90.
21. Russell, W. C., C. Newman, and D. H. Williamson. 1975. A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasma and viruses. Nature 253:461-462.
22. Schmidt, J., and V. Erfle. 1984. Elimination of mycoplasmas from cell cultures and establishment of mycoplasma-free cell lines. Exp. Cell Res. 152: 565-570.
23. Sheppard, J. D., C. Jumarie, D. G. Cooper, and R. Laprade. 1991. Ionic channels induced by surfactin in planar lipid bilayer membranes. Biochim. Biophys. Acta 1064:13-23.
24. Stanbridge, E. J., and C.-J. Doersen. 1978. Some effects that mycoplasmas have upon their infected host, p. 119-134. In G. J. McGarrity, D. G. Murphy, and W. W. Nichols (ed.), Mycoplasma infection of cell cultures. Plenum Press, New York, N.Y.
25. Toraya, T., T. Maoka, H. Tsuji, and M. Kobayashi. 1995. Purification and structural determination of an inhibitor of starfish oocyte maturation from a Bacillus species. Appl. Environ. Microbiol. 61:1799-1804.
26. Tsukagoshi, N., G. Tamura, and K. Arima. 1970. A novel protoplast-bursting factor (surfactin) obtained from Bacillus subtilis IAM 1213. II. The interaction of surfactin with bacterial membranes and lipids. Biochim. Biophys. Acta 196:211-214.
27. Uphoff, C. C, S. M. Gignac, and H. G. Drexler. 1992. Mycoplasma contamination in human leukemia cell lines. II. Elimination with various antibiotics. J. Immunol Methods 149:55-62.
28. van Kuppeveld, F. J. M., K.-E. Johansson, J. M. D. Galama, J. Kissing, G. Bölske, J. T. M. van der Logt, and W. J. G. Melchers. 1994. Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR. Appl. Environ. Microbiol. 60:149-152.
29. Vollenbroich, D., G. Pauli, J. Vater, M. Özel, and R. M. Kamp. Inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Submitted for publication.
30. World Health Organization. 1993. Report of the WHO Meeting on the Development of Vaginal Microbicides for the Prevention of Heterosexual Transmission of HIV. World Health Organization, Geneva, Switzerland.
31. Zuber, P., M. M. Nakano, and M. A. Marahiel. 1993. Peptide antibiotics of bacilli and other gram-positive bacteria, p. 897-916. In A. L. Sonenshein, J. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria: biochemistry, physiology, and molecular genetics. American Society for Microbiology, Washington, D.C.